The High Dose Aflibercept DME Trial
Retina Synthesis - A podcast by Retina Synthesis
Categories:
We discuss the baseline characteristics of eyes in the HD Aflibercept Phase III clinical trial and examine their ability for extended dosing with Dr. Eric Schneider of Tennessee Retina, Nashville, TN.
